Management of atypical chronic lymphocytic leukemia presenting with extreme leukocytosis

Atypical chronic lymphocytic lymphoma (CLL) with CCND1 translocation is poorly described, particularly in the era of modern inhibitors of the B‐cell receptor pathway. We present a patient with atypical CLL who had a significant response to ibrutinib, highlighting the effectiveness of this agent in h...

Descripción completa

Detalles Bibliográficos
Autores principales: Muddasani, Ramya, Talwar, Neel, Suarez‐Londono, Jaime Andres, Braunstein, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250984/
https://www.ncbi.nlm.nih.gov/pubmed/32477538
http://dx.doi.org/10.1002/ccr3.2773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250984/
https://www.ncbi.nlm.nih.gov/pubmed/32477538
http://dx.doi.org/10.1002/ccr3.2773

Ejemplares similares